Century Therapeutics, Inc. Common Stock IPSC
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-12T00:55:03.567Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2027-01-15
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T21:00:08.507096799Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-12T00:55:02.637082+00:00
Century Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | ||||||
| 45Δ | ||||||
| 50Δ | ||||||
| 55Δ | ||||||
| 60Δ | 2.13 | 95.0% | 8.4% | |||
| 65Δ | 1.80 | 175.0% | 32.0% | 2.28 | 99.0% | 7.0% |
| 70Δ | 1.56 | 142.6% | 18.3% | 2.44 | 103.0% | 5.7% |
| 75Δ | 3.10 | 122.6% | 4.5% | |||
| 80Δ | 4.12 | 153.0% | 3.3% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.13
- IV
- 95.0%
- B/E move
- 8.4%
65Δ
- Pseudo strike
- 1.80
- IV
- 175.0%
- B/E move
- 32.0%
- Pseudo strike
- 2.28
- IV
- 99.0%
- B/E move
- 7.0%
70Δ
- Pseudo strike
- 1.56
- IV
- 142.6%
- B/E move
- 18.3%
- Pseudo strike
- 2.44
- IV
- 103.0%
- B/E move
- 5.7%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.10
- IV
- 122.6%
- B/E move
- 4.5%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.12
- IV
- 153.0%
- B/E move
- 3.3%
Options history
Table
| Date | IV (%) |
|---|---|
| 244.20% | |
| 244.71% |
Biotechnology
IRD
Opus Genetics, Inc. (IRD) is a pioneering biotechnology company dedicated to advancing gene therapies for rare retinal diseases that affect vision. Utilizing cutting-edge…
More →IRON
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious…
More →IVA
Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH),…
More →IVVD
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious…
More →JANX
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology to treat cancer…
More →JAZZ
Description unavailable
More →